Standout Papers

Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rhe... 2022 2026 2023 2024113
  1. Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study (2022)
    Farzin Khosrow‐Khavar, Seoyoung C. Kim et al. Annals of the Rheumatic Diseases

Immediate Impact

43 standout
Sub-graph 1 of 13

Citing Papers

Tailoring traditional Chinese medicine in cancer therapy
2025 Standout
Global, regional, and national burden of atrial fibrillation and atrial flutter from 1990 to 2021: sex differences and global burden projections to 2046—a systematic analysis of the Global Burden of Disease Study 2021
2025 Standout
2 intermediate papers

Works of Su Been Lee being referenced

Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020
2022
Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study
2022 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Su Been Lee 72 60 22 136 23 338
Brittny Major 81 47 21 131 14 315
Erez Batat 65 69 1 139 21 383
Ali Avcı 56 45 100 21 336
Begoña Laíz 58 86 54 28 392
Antonio Aviña-Zubieta 25 50 10 158 16 365
Marcora Mandreoli 30 27 3 75 32 403
Michael G. Cohen 22 37 3 225 26 411
Hervé Lobbes 20 28 51 23 331
Hyoungyoung Kim 15 66 4 203 39 341
Yuan Kao 27 54 2 54 32 358

All Works

Loading papers...

Rankless by CCL
2026